Metlife Stock Current Valuation
| MWZ Stock | EUR 83.17 0.12 0.14% |
Valuation analysis of MetLife helps investors to measure MetLife's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that MetLife's price fluctuation is very steady at this time. Calculation of the real value of MetLife is based on 3 months time horizon. Increasing MetLife's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the MetLife stock is determined by what a typical buyer is willing to pay for full or partial control of MetLife. Since MetLife is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MetLife Stock. However, MetLife's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 83.17 | Real 93.23 | Hype 83.17 | Naive 84.15 |
The real value of MetLife Stock, also known as its intrinsic value, is the underlying worth of MetLife Company, which is reflected in its stock price. It is based on MetLife's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of MetLife's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of MetLife helps investors to forecast how MetLife stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MetLife more accurately as focusing exclusively on MetLife's fundamentals will not take into account other important factors: MetLife Company Current Valuation Analysis
MetLife's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current MetLife Current Valuation | 73.72 B |
Most of MetLife's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MetLife is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, MetLife has a Current Valuation of 73.72 B. This is 124.63% higher than that of the Financial Services sector and significantly higher than that of the Insurance - Life industry. The current valuation for all Germany stocks is significantly lower than that of the firm.
MetLife is regarded third in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Insurance - Life industry is now estimated at about 274.32 Billion. MetLife totals roughly 73.72 Billion in current valuation claiming about 27% of equities under Insurance - Life industry.MetLife Fundamentals
| Return On Equity | 0.0538 | |||
| Return On Asset | 0.0034 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 73.72 B | |||
| Shares Outstanding | 779.1 M | |||
| Shares Owned By Insiders | 16.00 % | |||
| Shares Owned By Institutions | 75.79 % | |||
| Price To Earning | 6.57 X | |||
| Price To Book | 2.24 X | |||
| Price To Sales | 0.72 X | |||
| Revenue | 69.9 B | |||
| Gross Profit | 15.56 B | |||
| EBITDA | 4.04 B | |||
| Net Income | 2.54 B | |||
| Cash And Equivalents | 27.89 B | |||
| Cash Per Share | 29.79 X | |||
| Total Debt | 17.8 B | |||
| Debt To Equity | 152.50 % | |||
| Current Ratio | 1.07 X | |||
| Book Value Per Share | 34.71 X | |||
| Cash Flow From Operations | 12.6 B | |||
| Earnings Per Share | 2.82 X | |||
| Price To Earnings To Growth | 5.11 X | |||
| Target Price | 71.8 | |||
| Beta | 1.08 | |||
| Market Capitalization | 52.21 B | |||
| Total Asset | 666.61 B | |||
| Z Score | 1.2 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 2.79 % | |||
| Net Asset | 666.61 B | |||
| Last Dividend Paid | 1.98 |
About MetLife Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MetLife's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MetLife using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MetLife based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in MetLife Stock
When determining whether MetLife is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if MetLife Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Metlife Stock. Highlighted below are key reports to facilitate an investment decision about Metlife Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in MetLife Stock please use our How to Invest in MetLife guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.